Cerus Quick Ratio 2006-2018 | CERS

Historical quick ratio values for Cerus (CERS) over the last 10 years.
Cerus Quick Ratio Historical Data
Date Current Assets - Inventory Current Liabilities Quick Ratio
2018-12-31 $0.13B $0.05B 2.53
2018-09-30 $0.14B $0.04B 3.17
2018-06-30 $0.13B $0.03B 4.57
2018-03-31 $0.12B $0.02B 5.10
2017-12-31 $0.08B $0.02B 3.26
2017-09-30 $0.07B $0.02B 3.11
2017-06-30 $0.06B $0.03B 2.46
2017-03-31 $0.06B $0.03B 2.38
2016-12-31 $0.08B $0.03B 3.03
2016-09-30 $0.10B $0.02B 4.19
2016-06-30 $0.10B $0.03B 3.89
2016-03-31 $0.11B $0.02B 4.74
2015-12-31 $0.12B $0.02B 5.47
2015-09-30 $0.12B $0.02B 5.80
2015-06-30 $0.13B $0.02B 5.89
2015-03-31 $0.12B $0.02B 5.29
2014-12-31 $0.06B $0.03B 2.05
2014-09-30 $0.06B $0.02B 2.80
2014-06-30 $0.06B $0.02B 2.62
2014-03-31 $0.06B $0.03B 2.05
2013-12-31 $0.07B $0.04B 1.65
2013-09-30 $0.06B $0.04B 1.45
2013-06-30 $0.07B $0.03B 2.46
2013-03-31 $0.08B $0.03B 2.74
2012-12-31 $0.03B $0.03B 1.32
2012-09-30 $0.03B $0.03B 1.24
2012-06-30 $0.03B $0.02B 1.39
2012-03-31 $0.04B $0.03B 1.38
2011-12-31 $0.03B $0.02B 1.58
2011-09-30 $0.02B $0.01B 1.49
2011-06-30 $0.02B $0.02B 1.04
2011-03-31 $0.03B $0.02B 1.36
2010-12-31 $0.04B $0.02B 1.82
2010-09-30 $0.02B $0.02B 1.22
2010-06-30 $0.02B $0.01B 1.58
2010-03-31 $0.02B $0.01B 2.17
2009-12-31 $0.03B $0.01B 1.91
2009-09-30 $0.03B $0.02B 1.76
2009-06-30 $0.02B $0.01B 1.57
2009-03-31 $0.02B $0.01B 1.98
2008-12-31 $0.03B $0.01B 2.40
2008-09-30 $0.04B $0.01B 3.00
2008-06-30 $0.05B $0.02B 2.95
2008-03-31 $0.06B $0.01B 4.05
2007-12-31 $0.07B $0.02B 3.65
2007-09-30 $0.08B $0.02B 4.88
2007-06-30 $0.08B $0.01B 5.93
2007-03-31 $0.09B $0.01B 8.13
2006-12-31 $0.10B $0.02B 6.81
2006-09-30 $0.08B $0.02B 5.01
2006-06-30 $0.08B $0.02B 4.74
2006-03-31 $0.09B $0.02B 4.16
2005-12-31 $0.05B $0.02B 2.19
2005-09-30 $0.05B $0.01B 4.10
2005-06-30 $0.06B $0.01B 4.10
2005-03-31 $0.06B $0.02B 3.98
Sector Industry Market Cap Revenue
Medical Medical Products Manufacturing $0.842B $0.061B
Cerus Corporation is developing medical products based on a platformtechnology that prevents nucleic acid replication. The company's initialapplication of this technology is the development of systems to inactivateviruses, bacteria and other pathogens in blood components used for transfusion. The company is also focusing research and development efforts on other potential health care applications for this platform technology, including pathogen inactivation of source plasma used for fractionation, improving the outcomes of stem cell transplantation.
Stock Name Country Market Cap PE Ratio
Abbott Laboratories (ABT) United States $137.409B 27.16
Medtronic (MDT) Ireland $121.535B 17.77
Stryker (SYK) United States $72.819B 26.70
Boston Scientific (BSX) United States $52.168B 25.43
Baxter (BAX) United States $39.788B 25.45
Zimmer Biomet Holdings (ZBH) United States $25.879B 16.57
Smith & Nephew SNATS (SNN) United Kingdom $17.424B 0.00
Canopy Growth (CGC) Canada $14.802B 0.00
ResMed (RMD) United States $14.533B 27.56
Aurora Cannabis (ACB) Canada $9.364B 66.07
Bio-Rad Laboratories (BIO) United States $9.204B 52.51
Hill-Rom Holdings (HRC) United States $6.966B 21.55
Perrigo (PRGO) Ireland $6.355B 10.30
Insulet (PODD) United States $5.761B 1943.60
GW Pharmaceuticals (GWPH) United Kingdom $4.977B 0.00
ICU Medical (ICUI) United States $4.744B 29.53
Haemonetics (HAE) United States $4.355B 38.63
Hutchison China MediTech (HCM) China $3.802B 0.00
Agios Pharmaceuticals (AGIO) United States $3.664B 0.00
Neogen (NEOG) United States $3.153B 48.42
NuVasive (NUVA) United States $2.938B 25.63
Quidel (QDEL) United States $2.527B 22.80
Aphria (APHA) $2.418B 107.33
National Vision Holdings (EYE) United States $2.298B 45.20
Cardiovascular Systems (CSII) United States $1.337B 960.00
HEXO (HEXO) $1.317B 0.00
VAREX IMAGING (VREX) United States $1.274B 24.95
Phibro Animal Health (PAHC) United States $1.273B 18.29
AtriCure (ATRC) United States $1.095B 0.00
MacroGenics (MGNX) United States $0.957B 0.00
Lantheus Holdings (LNTH) United States $0.914B 24.70
Omeros (OMER) United States $0.836B 0.00
PetIQ (PETQ) United States $0.835B 23.90
NanoString Technologies (NSTG) United States $0.726B 0.00
Meridian Bioscience (VIVO) United States $0.716B 21.32
Eagle Pharmaceuticals (EGRX) United States $0.674B 22.95
OraSure Technologies (OSUR) United States $0.671B 29.41
TG Therapeutics (TGTX) United States $0.619B 0.00
LeMaitre Vascular (LMAT) United States $0.587B 27.92
Evolus (EOLS) United States $0.577B 0.00
Surmodics (SRDX) United States $0.556B 80.90
Quanterix (QTRX) United States $0.531B 0.00
BioLife Solutions (BLFS) United States $0.350B 144.46
Insys Therapeutics (INSY) United States $0.342B 0.00
Vapotherm (VAPO) United States $0.335B 0.00
Rockwell Medical (RMTI) United States $0.325B 0.00
Utah Medical Products (UTMD) United States $0.313B 20.33
Bovie Medical (APYX) United States $0.271B 0.00
Owens & Minor (OMI) United States $0.265B 3.67
Neptune Technologies & Bioresources Inc (NEPT) Canada $0.242B 0.00
Cytosorbents (CTSO) United States $0.237B 0.00
Zynex (ZYXI) United States $0.142B 15.21
Fonar (FONR) United States $0.140B 7.48
Surface Oncology (SURF) United States $0.123B 0.00
Chimerix (CMRX) United States $0.103B 0.00
Female Health (VERU) United States $0.097B 0.00
Chembio Diagnostics (CEMI) United States $0.094B 0.00
InfuSystems Holdings (INFU) United States $0.089B 0.00
United-Guardian (UG) United States $0.087B 20.02
CAS Medical Systems (CASM) United States $0.071B 0.00
Neurotrope (NTRP) United States $0.067B 0.00
Trinity Biotech (TRIB) Ireland $0.062B 18.50
Oramed Pharmaceuticals (ORMP) United States $0.056B 0.00
ImmuCell (ICCC) United States $0.038B 0.00
Conatus Pharmaceuticals (CNAT) United States $0.036B 0.00
Valeritas Holdings (VLRX) United States $0.033B 0.00
Senestech (SNES) United States $0.032B 0.00
Myomo (MYO) United States $0.021B 0.00
Capricor Therapeutics (CAPR) United States $0.017B 0.00
InVivo Therapeutics Holdings (NVIV) United States $0.015B 0.00
Akers Biosciences Inc (AKER) United States $0.012B 0.00
Cellectar Biosciences (CLRB) United States $0.011B 0.00
NeuroMetrix (NURO) United States $0.008B 15.14